Journal of Education, Health and Sport (Jul 2020)

Evaluation of the effectiveness using nanomodified polipropilene meshes at laparoscopic operations of a hernia of a stomach

  • Ruslan Lutkovskyi

DOI
https://doi.org/10.12775/JEHS.2020.10.07.036
Journal volume & issue
Vol. 10, no. 7
pp. 343 – 349

Abstract

Read online

In laparoscopic surgical treatment of incisional abdominal hernia (AH) of great sizes, using polypropylene mesh, buth this is accompanied by a fairly high freguency of postoperative complications from the postoperative wound.In our view, the use of a polypropylene mesh modified by carbon nanotubes and an antiseptic of polyhexamethleneguanidme chloride the results of surgical treatment of AH.Aim – to improve the results of laparoscopic surgical treatment of incisional abdominal hernias of great proportions by using in combination with nanomodified polypropylene mesh.Materials and methods. The analysis of laparoscopic surgical treatment of 240 patients with AH of great sizes has been performed. Depending on the type of mesh used during laparoscopic surgical treatment, patients were divided into 2 groups. In 120 (50%) of Group I patients, the component aloplasty with the use of a nanomodified polypropylene mesh. In the 2nd group, 120 (50%) patients used the aloplasty with the use of a classic polypropylene mesh.Results and discussion. Statistically significant results were obtained in patients of Group I compared to Group II: seroma was in 17 (7.0±1.2%) in Group II compared to 4 (1.8±0.3%) in Group I (p<0.05). Chronic pain in the abdominal wall in 6 – 8 months after surgery was observed in 13 (5.3±0.4)% patients in group II and in 0 group I (p>0.05), recurrences of hernia were found in 13 (5.3±0.4%) patients of group II, in group I – in 4 (1.8±0.6)% (p<0.05). The terms of stay of patients of group II on inpatient treatment – 5,3±2,1 days group I – 2,1±1,2 days.Conclusion. Laparoscopic operacione treatment of UH using nanomodified polypropylene mesh antiseptic the use of the classical polypropylene mesh, namely, reducing the freguency of seroma from 7.0±1.2% in the II group of patients to 1.8±0.3% in group I, chronic postoperative pain – from 5.3±0.4% to 0, recurrence of hernia–from 5.3±0.4% to 1.8±0.6%.

Keywords